CHRISTINA CALLIHAN: Open Payments
NPI 1164096483 · RICHMOND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$46,196 in 196 payments from 14 companies in 2025. Trend: 2023 $575 · 2024 $977 · 2025 $46,196
Honoraria: $31,639Travel & lodging: $4,375Speaker / faculty: $3,805Food & beverage: $3,504Consulting: $2,873
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 59 | $35,411 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 32 | $7,033 |
| E.R. Squibb & Sons, L.L.C. | 19 | $1,352 |
| ABBVIE INC. | 25 | $1,304 |
| Vanda Pharmaceuticals Inc. | 28 | $553 |
| Alkermes, Inc. | 13 | $223 |
| Otsuka America Pharmaceutical, Inc. | 11 | $138 |
| Almatica Pharma LLC | 2 | $53 |
| Indivior Inc. | 2 | $30 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
Products named: Auvelity, CAPLYTA, VRAYLAR, FANAPT, COBENFY, LYBALVI, ABILIFY MAINTENA, REXULTI.
Industry payments across KY — which companies pay providers there.
